Open Wavelength

This piece follows the previous two entries in this series. Those came from the inside, how my autistic brain uses routine and natural tools to stay regulated, and how society decides which kinds of dependence are acceptable. This one comes from the outside. I was listening to a Huberman Lab episode on erasing fear and trauma, and it hit me how often even serious science repeats the same structural bias: assuming every brain processes life the same way, and every form of healing must fit one formula.

1. The Missing First Question

Before we talk about trauma or healing, shouldn't we ask how a person's brain actually works? Huberman frames fear as a top-down process, something the prefrontal cortex can regulate once we think our way through it. That makes sense for some nervous systems. But what about those of us who run bottom-up, who feel before we think?

When fear hits my system, it's not a concept. It's a surge. By the time my mind has a name for it, my body is already halfway through the reaction. You can't talk someone out of that with logic. And yet almost every mainstream therapy, from CBT to exposure protocols, starts with the same instruction: think differently. If you build your healing methods for top-down processors, the rest of us end up being treated like broken machines instead of different operating systems.

2. Fear Isn't the Enemy

The episode keeps circling the question everyone wants answered: how do we eliminate fear? That's where I pull back. Eliminating fear sounds a lot like eliminating life. Fear, joy, anger, awe, they're all voltage. They're what tell us we're awake. A world without emotional range isn't peace. It's flatline.

The goal shouldn't be erasure. It should be precision. Learn the rhythm of your own system so you can ride the current instead of getting thrown by it. That's a very different objective, and it produces very different therapeutic approaches.

3. The Science Filter

When Huberman gets to treatment options, the focus goes to ketamine and MDMA. Both synthetic, both heavily studied, both easy to regulate and patent. Psilocybin, natural and showing equal or better results in several trials, gets comparatively little airtime. It's not that the science is wrong. It's that the research economy is tilted. What can be owned gets studied. What grows from the ground gets sidelined.

That's the same pattern from Part I: the approved dependency gets the clean signal, the natural one gets the stigma, even when the underlying chemistry isn't that different and the outcomes data increasingly favors the natural route.

4. So What Now

I don't think the answer is to reject science. I think it's to widen its scope. Let lived experience and natural intelligence back into the conversation. Healing isn't one algorithm. It's a spectrum, just like the brains we're trying to heal.

Maybe the next evolution of neuroscience isn't a new drug or a new machine. Maybe it's the humility to ask: whose nervous system are we actually talking about? And to wait for an honest answer before building the protocol.